Rates of proliferation, apoptosis and cytokine expression were measured in
bone marrow (BM) biopsies of 164 myelodysplastic syndrome (MDS) patients. T
here were 107 males and 57 females. Median age was 69 years and 101 had ref
ractory, anemia (RA), 17 RA with ringed sideroblasts (RARS), 38 with RA and
excess blasts (RAEB) and 8 with RAEB in transformation (RAEB-t). Apoptosis
measured by in-situ end labeling (ISEL) was directly related to the number
of macrophages (p = 0.028, n = 83). Mean tumor necrosis factor alpha (TNF-
alpha) and ISEL positivity were higher in RAEB + RAEB-t patients (p = 0.055
4 and p = 0.06 respectively) while hemoglobin was higher for RA + RARS grou
p (p = 0.0472). Patients with high apoptosis had lower white blood cell cou
nts (p = 0.0009), lower percentage of blasts (p = 0.0009) and higher number
of macrophages (p= 0.0086). We conclude that measurements of apoptosis, pr
oliferation and cytokine expression provide important biological informatio
n which helps to distinguish RA + RARS patients from RAEB + RAEB-t patients
, and may be of additive prognostic significance.